Status | Study |
Active, not recruiting |
Study Name: Systems Biology of PNEUMOVAX®23 and PREVNAR 13® Condition: Pneumococcal Infection Date: 2011-03-01 Interventions: Biological: PNEUMOVAX and PREVNAR |
Completed |
Study Name: A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003 AM2) Condition: Pneumococcal Infections Date: 2010-10-04 Interventions: Biological: V114 Aluminum-adjuvanted |
Completed |
Study Name: Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease Condition: Invasive Pneumococcal Disease Date: 2010-05-20 Interventions: Other: No intervention No intervention |
Completed |
Study Name: Child Pneumococcal Serotype Epidemiology In Greece Condition: Pneumococcal Disease Date: 2010-04-23 Interventions: Other: no intervention There is no intervention. This is a non interventional study. |
Completed |
Study Name: Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47 Condition: Pneumococcal Infections Date: 2009-03-31 Interventions: Biological: IC47 solution/suspension for i.m. injection dosage: 30/150 mcg frequency: 3 times at Day 0, |
Withdrawn |
Study Name: A Retrospective Epidemiological Study on Pneumococcal Infection in Children in Ministry of Health Hospital at EHSA Region in the Eastern Province Condition: Pneumococcal Infection Date: 2009-02-10 Interventions: Biological: serotypes and resistance screening patients with invasive pneumococci |
Completed |
Study Name: Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007) Condition: Pneumococcal Infection Date: 2007-11-19 Interventions: Biological: pneumococcal 23v polysaccharide vaccine Duration of Treatment: Single vaccination on Day 1 |
Completed |
Study Name: Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011) Condition: Pneumococcal Infection Date: 2007-07-03 Interventions: Biological: Pneumococcal Vaccine, Polyvalent (23-valent) Other Names: V |
Completed |
Study Name: Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults Condition: Pneumococcal Infections Date: 2007-06-26 Interventions: Biological: 13-valent pneumococcal conjugate vaccine |
Completed |
Study Name: Safety and Local Tolerability of Prevenar in Indian Children Condition: Pneumococcal Infections Date: 2007-06-18 Interventions: Biological: pneumococcal conjugate vaccine |